Viewing Study NCT00317759


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-01-18 @ 7:19 AM
Study NCT ID: NCT00317759
Status: COMPLETED
Last Update Posted: 2015-10-01
First Post: 2006-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV melanoma View
None recurrent melanoma View